<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33672031</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Feb</Month><Day>15</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Mast Cell and Astrocyte Hemichannels and Their Role in Alzheimer's Disease, ALS, and Harmful Stress Conditions.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1924</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22041924</ELocationID><Abstract><AbstractText>Considered relevant during allergy responses, numerous observations have also identified mast cells (MCs) as critical effectors during the progression and modulation of several neuroinflammatory conditions, including Alzheimer's disease (AD) and amyotrophic lateral sclerosis (ALS). MC granules contain a plethora of constituents, including growth factors, cytokines, chemokines, and mitogen factors. The release of these bioactive substances from MCs occurs through distinct pathways that are initiated by the activation of specific plasma membrane receptors/channels. Here, we focus on hemichannels (HCs) formed by connexins (Cxs) and pannexins (Panxs) proteins, and we described their contribution to MC degranulation in AD, ALS, and harmful stress conditions. Cx/Panx HCs are also expressed by astrocytes and are likely involved in the release of critical toxic amounts of soluble factors-such as glutamate, adenosine triphosphate (ATP), complement component 3 derivate C3a, tumor necrosis factor (TNF&#x3b1;), apoliprotein E (ApoE), and certain miRNAs-known to play a role in the pathogenesis of AD, ALS, and other neurodegenerative disorders. We propose that blocking HCs on MCs and glial cells offers a promising novel strategy for ameliorating the progression of neurodegenerative diseases by reducing the release of cytokines and other pro-inflammatory compounds.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Harcha</LastName><ForeName>Paloma A</ForeName><Initials>PA</Initials><Identifier Source="ORCID">0000-0001-8964-4301</Identifier><AffiliationInfo><Affiliation>Instituto de Neurociencia, Centro Interdisciplinario de Neurociencia de Valpara&#xed;so, Valpara&#xed;so 2381850, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xe9;s</LastName><ForeName>Polett</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences (ICB), Faculty of Medicine &amp; Faculty of Life Sciences, Universidad Andres Bello, Santiago 8370186, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CARE Biomedical Research Center, Faculty of Biological Sciences, Pontificia Universidad Cat&#xf3;lica de Chile, Santiago 8330005, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arredondo</LastName><ForeName>Cristian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences (ICB), Faculty of Medicine &amp; Faculty of Life Sciences, Universidad Andres Bello, Santiago 8370186, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CARE Biomedical Research Center, Faculty of Biological Sciences, Pontificia Universidad Cat&#xf3;lica de Chile, Santiago 8330005, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez</LastName><ForeName>Germ&#xe1;n</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences (ICB), Faculty of Medicine &amp; Faculty of Life Sciences, Universidad Andres Bello, Santiago 8370186, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CARE Biomedical Research Center, Faculty of Biological Sciences, Pontificia Universidad Cat&#xf3;lica de Chile, Santiago 8330005, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;ez</LastName><ForeName>Juan C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Instituto de Neurociencia, Centro Interdisciplinario de Neurociencia de Valpara&#xed;so, Valpara&#xed;so 2381850, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Fisiolog&#xed;a, Facultad de Ciencias Biol&#xf3;gicas, Pontificia Universidad Cat&#xf3;lica de Chile, Santiago 8331150, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Zundert</LastName><ForeName>Brigitte</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences (ICB), Faculty of Medicine &amp; Faculty of Life Sciences, Universidad Andres Bello, Santiago 8370186, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CARE Biomedical Research Center, Faculty of Biological Sciences, Pontificia Universidad Cat&#xf3;lica de Chile, Santiago 8330005, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01605, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017630">Connexins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007473">Ion Channels</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015550" MajorTopicYN="N">Cell Degranulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017630" MajorTopicYN="N">Connexins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007473" MajorTopicYN="N">Ion Channels</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008407" MajorTopicYN="N">Mast Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013312" MajorTopicYN="Y">Stress, Physiological</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">connexin</Keyword><Keyword MajorTopicYN="N">degranulation</Keyword><Keyword MajorTopicYN="N">gap junction channels</Keyword><Keyword MajorTopicYN="N">glial cells</Keyword><Keyword MajorTopicYN="N">hemichannels</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">mast cells</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">pannexin</Keyword><Keyword MajorTopicYN="N">pro-inflammatory compounds</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>6</Day><Hour>1</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33672031</ArticleId><ArticleId IdType="pmc">PMC7919494</ArticleId><ArticleId IdType="doi">10.3390/ijms22041924</ArticleId><ArticleId IdType="pii">ijms22041924</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dropp J.J. Mast cells in the central nervous system of several rodents. Anat. Rec. 1972;174:227&#x2013;237. doi: 10.1002/ar.1091740207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ar.1091740207</ArticleId><ArticleId IdType="pubmed">4627786</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibrahim M.Z.M. The mast cells of the mammalian central nervous system. J. Neurol. Sci. 1974;21:479&#x2013;499. doi: 10.1016/0022-510X(74)90044-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(74)90044-6</ArticleId><ArticleId IdType="pubmed">4207062</ArticleId></ArticleIdList></Reference><Reference><Citation>Kr&#xfc;ger P.G. Demonstration of mast cells in the albino rat brain. Experientia. 1974;30:810&#x2013;811. doi: 10.1007/BF01924200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01924200</ArticleId><ArticleId IdType="pubmed">4847679</ArticleId></ArticleIdList></Reference><Reference><Citation>Dropp J.J. Mast cells in mammalian brain. Acta Anat. 1976;94:1&#x2013;21. doi: 10.1159/000144540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000144540</ArticleId><ArticleId IdType="pubmed">961335</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C. Mast cells: The immune gate to the brain. Life Sci. 1990;46:607&#x2013;617. doi: 10.1016/0024-3205(90)90129-F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0024-3205(90)90129-F</ArticleId><ArticleId IdType="pubmed">2407920</ArticleId></ArticleIdList></Reference><Reference><Citation>Crivellato E., Beltrami C.A., Mallardi F., Ribatti D. Paul Ehrlich&#x2019;s doctoral thesis: A milestone in the study of mast cells. Br. J. Haematol. 2003;123:19&#x2013;21. doi: 10.1046/j.1365-2141.2003.04573.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2141.2003.04573.x</ArticleId><ArticleId IdType="pubmed">14510938</ArticleId></ArticleIdList></Reference><Reference><Citation>Metcalfe D.D., Baram D., Mekori Y.A. Mast cells. Physiol. Rev. 1997;77:1033&#x2013;1079. doi: 10.1152/physrev.1997.77.4.1033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.1997.77.4.1033</ArticleId><ArticleId IdType="pubmed">9354811</ArticleId></ArticleIdList></Reference><Reference><Citation>Dudeck A., K&#xf6;berle M., Goldmann O., Meyer N., Dudeck J., Lemmens S., Rohde M., Rold&#xe1;n N.G., Dietze-Schwonberg K., Orinska Z., et al. Mast cells as protectors of health. J. Allergy Clin. Immunol. 2019;144:S4&#x2013;S18. doi: 10.1016/j.jaci.2018.10.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2018.10.054</ArticleId><ArticleId IdType="pubmed">30468774</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimitriadou V., Lambracht-Hall M., Reichler J., Theoharides T.C. Histochemical and ultrastructural characteristics of rat brain perivascular mast cells stimulated with compound 48/80 and carbachol. Neuroscience. 1990;39:209&#x2013;224. doi: 10.1016/0306-4522(90)90234-U.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0306-4522(90)90234-U</ArticleId><ArticleId IdType="pubmed">1708466</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukai K., Tsai M., Saito H., Galli S.J. Mast cells as sources of cytokines, chemokines, and growth factors. Immunol. Rev. 2018;282:121&#x2013;150. doi: 10.1111/imr.12634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12634</ArticleId><ArticleId IdType="pmc">PMC5813811</ArticleId><ArticleId IdType="pubmed">29431212</ArticleId></ArticleIdList></Reference><Reference><Citation>Redegeld F.A., Yu Y., Kumari S., Charles N., Blank U. Non-IgE mediated mast cell activation. Immunol. Rev. 2018;282:87&#x2013;113. doi: 10.1111/imr.12629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12629</ArticleId><ArticleId IdType="pubmed">29431205</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Tsilioni I., Ren H. Recent advances in our understanding of mast cell activation&#x2014;Or should it be mast cell mediator disorders? Expert Rev. Clin. Immunol. 2019;15:639&#x2013;656. doi: 10.1080/1744666X.2019.1596800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2019.1596800</ArticleId><ArticleId IdType="pmc">PMC7003574</ArticleId><ArticleId IdType="pubmed">30884251</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon T.C., Befus A.D., Kulka M. Mast Cell Mediators: Their Differential Release and the Secretory Pathways Involved. Front. Immunol. 2014;5 doi: 10.3389/fimmu.2014.00569.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00569</ArticleId><ArticleId IdType="pmc">PMC4231949</ArticleId><ArticleId IdType="pubmed">25452755</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H., Bin N.-R., Sugita S. Diverse exocytic pathways for mast cell mediators. Biochem. Soc. Trans. 2018;46:235&#x2013;247. doi: 10.1042/BST20170450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST20170450</ArticleId><ArticleId IdType="pmc">PMC5986074</ArticleId><ArticleId IdType="pubmed">29472369</ArticleId></ArticleIdList></Reference><Reference><Citation>Blank U. The mechanisms of exocytosis in mast cells. Adv. Exp. Med. Biol. 2011;716:107&#x2013;122. doi: 10.1007/978-1-4419-9533-9_7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4419-9533-9_7</ArticleId><ArticleId IdType="pubmed">21713654</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein O., Sagi-Eisenberg R. Anaphylactic Degranulation of Mast Cells: Focus on Compound Exocytosis. J. Immunol. Res. 2019;2019:1&#x2013;12. doi: 10.1155/2019/9542656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/9542656</ArticleId><ArticleId IdType="pmc">PMC6442490</ArticleId><ArticleId IdType="pubmed">31011586</ArticleId></ArticleIdList></Reference><Reference><Citation>Raposo G., Tenza D., Mecheri S., Peronet R., Bonnerot C., Desaymard C. Accumulation of Major Histocompatibility Complex Class II Molecules in Mast Cell Secretory Granules and Their Release upon Degranulation. Mol. Biol. Cell. 1997;8:2631&#x2013;2645. doi: 10.1091/mbc.8.12.2631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.8.12.2631</ArticleId><ArticleId IdType="pmc">PMC25733</ArticleId><ArticleId IdType="pubmed">9398681</ArticleId></ArticleIdList></Reference><Reference><Citation>Dvorak A.M. Ultrastructural Studies of Human Basophils and Mast Cells. J. Histochem. Cytochem. 2005;53:1043&#x2013;1070. doi: 10.1369/jhc.5R6647.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1369/jhc.5R6647.2005</ArticleId><ArticleId IdType="pubmed">15923353</ArticleId></ArticleIdList></Reference><Reference><Citation>Puri N., Roche P.A. Mast cells possess distinct secretory granule subsets whose exocytosis is regulated by different SNARE isoforms. Proc. Natl. Acad. Sci. USA. 2008;105:2580&#x2013;2585. doi: 10.1073/pnas.0707854105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0707854105</ArticleId><ArticleId IdType="pmc">PMC2268179</ArticleId><ArticleId IdType="pubmed">18250339</ArticleId></ArticleIdList></Reference><Reference><Citation>Wernersson S., Pejler G. Mast cell secretory granules: Armed for battle. Nat. Rev. Immunol. 2014;14:478&#x2013;494. doi: 10.1038/nri3690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3690</ArticleId><ArticleId IdType="pubmed">24903914</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorentz A., Baumann A., Vitte J., Blank U. The SNARE Machinery in Mast Cell Secretion. Front. Immunol. 2012;3 doi: 10.3389/fimmu.2012.00143.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2012.00143</ArticleId><ArticleId IdType="pmc">PMC3367400</ArticleId><ArticleId IdType="pubmed">22679448</ArticleId></ArticleIdList></Reference><Reference><Citation>Blank U., Madera-Salcedo I.K., Danelli L., Claver J., Tiwari N., S&#xe3;nchez-Miranda E., V&#xe3;zquez-Victorio G., Ram&#xed;rez-Valadez K.A., Macias-Silva M., Gonz&#xe3;lez-Espinosa C. Vesicular Trafficking and Signaling for Cytokine and Chemokine Secretion in Mast Cells. Front. Immunol. 2014;5 doi: 10.3389/fimmu.2014.00453.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00453</ArticleId><ArticleId IdType="pmc">PMC4170139</ArticleId><ArticleId IdType="pubmed">25295038</ArticleId></ArticleIdList></Reference><Reference><Citation>Espinosa E., Valitutti S. New roles and controls of mast cells. Curr. Opin. Immunol. 2018;50:39&#x2013;47. doi: 10.1016/j.coi.2017.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2017.10.012</ArticleId><ArticleId IdType="pubmed">29144996</ArticleId></ArticleIdList></Reference><Reference><Citation>Harcha P.A., L&#xf3;pez X., S&#xe1;ez P.J., Fern&#xe1;ndez P., Barr&#xed;a I., Mart&#xed;nez A.D., S&#xe1;ez J.C. Pannexin-1 Channels Are Essential for Mast Cell Degranulation Triggered During Type I Hypersensitivity Reactions. Front. Immunol. 2019;10 doi: 10.3389/fimmu.2019.02703.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02703</ArticleId><ArticleId IdType="pmc">PMC6896164</ArticleId><ArticleId IdType="pubmed">31849935</ArticleId></ArticleIdList></Reference><Reference><Citation>Harcha P.A., Vargas R.A., Yi C., Koulakoff A., Giaume C., Saez J.C. Hemichannels Are Required for Amyloid -Peptide-Induced Degranulation and Are Activated in Brain Mast Cells of APPswe/PS1dE9 Mice. J. Neurosci. 2015;35:9526&#x2013;9538. doi: 10.1523/JNEUROSCI.3686-14.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3686-14.2015</ArticleId><ArticleId IdType="pmc">PMC6605189</ArticleId><ArticleId IdType="pubmed">26109673</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogasawara T., Murakami M., Suzuki-Nishimura T., Uchida M.K., Kudo I. Mouse bone marrow-derived mast cells undergo exocytosis, prostanoid generation, and cytokine expression in response to G protein-activating polybasic compounds after coculture with fibroblasts in the presence of c-kit ligand. J. Immunol. 1997;158:393&#x2013;404.</Citation><ArticleIdList><ArticleId IdType="pubmed">8977215</ArticleId></ArticleIdList></Reference><Reference><Citation>McNeil B.D., Pundir P., Meeker S., Han L., Undem B.J., Kulka M., Dong X. Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions. Nature. 2015;519:237&#x2013;241. doi: 10.1038/nature14022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14022</ArticleId><ArticleId IdType="pmc">PMC4359082</ArticleId><ArticleId IdType="pubmed">25517090</ArticleId></ArticleIdList></Reference><Reference><Citation>Karimi K., Kool M., Nijkamp F.P., Redegeld F.A. Substance P can stimulate prostaglandin D2 and leukotriene C4 generation without granule exocytosis in murine mast cells. Eur. J. Pharmacol. 2004;489:49&#x2013;54. doi: 10.1016/j.ejphar.2004.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2004.03.003</ArticleId><ArticleId IdType="pubmed">15063154</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynier-Rebuffel A.M., Mathiau P., Callebert J., Dimitriadou V., Farjaudon N., Kacem K., Launay J.M., Seylaz J., Abineau P. Substance P, calcitonin gene-related peptide, and capsaicin release serotonin from cerebrovascular mast cells. Am. J. Physiol. Integr. Comp. Physiol. 1994;267:R1421&#x2013;R1429. doi: 10.1152/ajpregu.1994.267.5.R1421.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpregu.1994.267.5.R1421</ArticleId><ArticleId IdType="pubmed">7526717</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulka M., Sheen C.H., Tancowny B.P., Grammer L.C., Schleimer R.P. Neuropeptides activate human mast cell degranulation and chemokine production. Immunology. 2008;123:398&#x2013;410. doi: 10.1111/j.1365-2567.2007.02705.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2567.2007.02705.x</ArticleId><ArticleId IdType="pmc">PMC2433325</ArticleId><ArticleId IdType="pubmed">17922833</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis R.A., Soter N.A., Diamond P.T., Austen K.F., Oates J.A., Roberts L.J. Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J. Immunol. 1982;129:1627&#x2013;1631.</Citation><ArticleIdList><ArticleId IdType="pubmed">6809826</ArticleId></ArticleIdList></Reference><Reference><Citation>Burd P.R., Rogers H.W., Gordon J.R., Martin C.A., Jayaraman S., Wilson S.D., Dvorak A.M., Galli S.J., Dorf M.E. Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J. Exp. Med. 1989;170:245&#x2013;257. doi: 10.1084/jem.170.1.245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.170.1.245</ArticleId><ArticleId IdType="pmc">PMC2189362</ArticleId><ArticleId IdType="pubmed">2473161</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald A.J., Pick J., Bissonnette E.Y., Befus A.D. Rat mucosal mast cells: The cultured bone marrow-derived mast cell is biochemically and functionally analogous to its counterpart in vivo. Immunology. 1998;93:533&#x2013;539. doi: 10.1046/j.1365-2567.1998.00465.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2567.1998.00465.x</ArticleId><ArticleId IdType="pmc">PMC1364132</ArticleId><ArticleId IdType="pubmed">9659226</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilchrist M., McCauley S.D., Befus A.D. Expression, localization, and regulation of NOS in human mast cell lines: Effects on leukotriene production. Blood. 2004;104:462&#x2013;469. doi: 10.1182/blood-2003-08-2990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2003-08-2990</ArticleId><ArticleId IdType="pubmed">15044250</ArticleId></ArticleIdList></Reference><Reference><Citation>Swindle E.J., Metcalfe D.D., Coleman J.W. Rodent and Human Mast Cells Produce Functionally Significant Intracellular Reactive Oxygen Species but Not Nitric Oxide. J. Biol. Chem. 2004;279:48751&#x2013;48759. doi: 10.1074/jbc.M409738200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M409738200</ArticleId><ArticleId IdType="pubmed">15361524</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Sam S.W., Yip K.H., Lau H.Y.A. Functional characterization of human mast cells cultured from adult peripheral blood. Int. Immunopharmacol. 2006;6:839&#x2013;847. doi: 10.1016/j.intimp.2005.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2005.12.004</ArticleId><ArticleId IdType="pubmed">16546715</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon T.C., Yoshimura T., Parsons T., Befus A.D. Microenvironmental regulation of inducible nitric oxide synthase expression and nitric oxide production in mouse bone marrow-derived mast cells. J. Leukoc. Biol. 2012;91:581&#x2013;590. doi: 10.1189/jlb.0811436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0811436</ArticleId><ArticleId IdType="pubmed">22262798</ArticleId></ArticleIdList></Reference><Reference><Citation>McCurdy J.D., Lin T.J., Marshall J.S. Toll-like receptor 4-mediated activation of murine mast cells. J. Leukoc. Biol. 2001;70:977&#x2013;984.</Citation><ArticleIdList><ArticleId IdType="pubmed">11739561</ArticleId></ArticleIdList></Reference><Reference><Citation>King C.A., Marshall J.S., Alshurafa H., Anderson R. Release of Vasoactive Cytokines by Antibody-Enhanced Dengue Virus Infection of a Human Mast Cell/Basophil Line. J. Virol. 2000;74:7146&#x2013;7150. doi: 10.1128/JVI.74.15.7146-7150.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.15.7146-7150.2000</ArticleId><ArticleId IdType="pmc">PMC112233</ArticleId><ArticleId IdType="pubmed">10888655</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulka M., Alexopoulou L., Flavell R.A., Metcalfe D.D. Activation of mast cells by double-stranded RNA: Evidence for activation through Toll-like receptor 3. J. Allergy Clin. Immunol. 2004;114:174&#x2013;182. doi: 10.1016/j.jaci.2004.03.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2004.03.049</ArticleId><ArticleId IdType="pubmed">15241362</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundstrom J.B., Hair G.A., Ansari A.A., Secor W.E., Gilfillan A.M., Metcalfe D.D., Kirshenbaum A.S. IgE-Fc&#x3b5;RI Interactions Determine HIV Coreceptor Usage and Susceptibility to Infection during Ontogeny of Mast Cells. J. Immunol. 2009;182:6401&#x2013;6409. doi: 10.4049/jimmunol.0801481.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0801481</ArticleId><ArticleId IdType="pmc">PMC2791323</ArticleId><ArticleId IdType="pubmed">19414793</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Lati S.G., Church M.K., Dahinden C.A. Complement Peptides C3a- and C5a-Induced Mediator Release from Dissociated Human Skin Mast Cells. J. Investig. Dermatol. 1994;102:803&#x2013;806. doi: 10.1111/1523-1747.ep12378589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1523-1747.ep12378589</ArticleId><ArticleId IdType="pubmed">7513741</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartmann K., Henz B.M., Kr&#xfc;ger-Krasagakes S., K&#xf6;hl J., Burger R., Guhl S., Haase I., Lippert U., Zuberbier T. C3a and C5a stimulate chemotaxis of human mast cells. Blood. 1997;89:2863&#x2013;2870. doi: 10.1182/blood.V89.8.2863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V89.8.2863</ArticleId><ArticleId IdType="pubmed">9108406</ArticleId></ArticleIdList></Reference><Reference><Citation>Erdei A., M&#xe1;rton A., Hajna P., G&#xe1;bor T., Israel P. Regulation of mast cell activation by complement-derived peptides. Immunol. Lett. 2004;92:39&#x2013;42. doi: 10.1016/j.imlet.2003.11.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2003.11.019</ArticleId><ArticleId IdType="pubmed">15081525</ArticleId></ArticleIdList></Reference><Reference><Citation>Esseltine J.L., Laird D.W. Next-Generation Connexin and Pannexin Cell Biology. Trends Cell Biol. 2016;26:944&#x2013;955. doi: 10.1016/j.tcb.2016.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2016.06.003</ArticleId><ArticleId IdType="pubmed">27339936</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyer E.C., Berthoud V.M. Gap junction gene and protein families: Connexins, innexins, and pannexins. Biochim. Biophys. Acta. 2018;1860:5&#x2013;8. doi: 10.1016/j.bbamem.2017.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamem.2017.05.016</ArticleId><ArticleId IdType="pmc">PMC5704981</ArticleId><ArticleId IdType="pubmed">28559187</ArticleId></ArticleIdList></Reference><Reference><Citation>Giaume C., Naus C.C., S&#xe1;ez J.C., Leybaert L. Glial Connexins and Pannexins in the Healthy and Diseased Brain. Physiol. Rev. 2021;101:93&#x2013;145. doi: 10.1152/physrev.00043.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00043.2018</ArticleId><ArticleId IdType="pubmed">32326824</ArticleId></ArticleIdList></Reference><Reference><Citation>Stout C.E., Costantin J.L., Naus C.C.G., Charles A.C. Intercellular Calcium Signaling in Astrocytes via ATP Release through Connexin Hemichannels. J. Biol. Chem. 2002;277:10482&#x2013;10488. doi: 10.1074/jbc.M109902200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109902200</ArticleId><ArticleId IdType="pubmed">11790776</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruzzone R., Barbe M.T., Jakob N.J., Monyer H. Pharmacological properties of homomeric and heteromeric pannexin hemichannels expressed in Xenopus oocytes. J. Neurochem. 2005;92:1033&#x2013;1043. doi: 10.1111/j.1471-4159.2004.02947.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2004.02947.x</ArticleId><ArticleId IdType="pubmed">15715654</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherian P.P., Siller-Jackson A.J., Gu S., Wang X., Bonewald L.F., Sprague E., Jiang J.X. Mechanical Strain Opens Connexin 43 Hemichannels in Osteocytes: A Novel Mechanism for the Release of Prostaglandin. Mol. Biol. Cell. 2005;16:3100&#x2013;3106. doi: 10.1091/mbc.e04-10-0912.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e04-10-0912</ArticleId><ArticleId IdType="pmc">PMC1165395</ArticleId><ArticleId IdType="pubmed">15843434</ArticleId></ArticleIdList></Reference><Reference><Citation>Retamal M.A., Froger N., Palacios-Prado N., Ezan P., Saez P.J., Saez J.C., Giaume C. Cx43 Hemichannels and Gap Junction Channels in Astrocytes Are Regulated Oppositely by Proinflammatory Cytokines Released from Activated Microglia. J. Neurosci. 2007;27:13781&#x2013;13792. doi: 10.1523/JNEUROSCI.2042-07.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2042-07.2007</ArticleId><ArticleId IdType="pmc">PMC6673621</ArticleId><ArticleId IdType="pubmed">18077690</ArticleId></ArticleIdList></Reference><Reference><Citation>Riquelme M.A., Cea L.A., Vega J.L., Boric M.P., Monyer H., Bennett M.V.L., Frank M., Willecke K., S&#xe1;ez J.C. The ATP required for potentiation of skeletal muscle contraction is released via pannexin hemichannels. Neuropharmacology. 2013;75:594&#x2013;603. doi: 10.1016/j.neuropharm.2013.03.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2013.03.022</ArticleId><ArticleId IdType="pubmed">23583931</ArticleId></ArticleIdList></Reference><Reference><Citation>Eugenin E.A. Role of Connexin/Pannexin containing channels in infectious diseases. FEBS Lett. 2014;588:1389&#x2013;1395. doi: 10.1016/j.febslet.2014.01.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2014.01.030</ArticleId><ArticleId IdType="pmc">PMC4229019</ArticleId><ArticleId IdType="pubmed">24486013</ArticleId></ArticleIdList></Reference><Reference><Citation>Eugenin E.A. Role of cell-to-cell communication in cancer: New features, insights, and directions. Cancer Rep. 2019;2 doi: 10.1002/cnr2.1228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cnr2.1228</ArticleId><ArticleId IdType="pubmed">32729188</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;ez J.C., Leybaert L. Hunting for connexin hemichannels. FEBS Lett. 2014;588:1205&#x2013;1211. doi: 10.1016/j.febslet.2014.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2014.03.004</ArticleId><ArticleId IdType="pubmed">24631534</ArticleId></ArticleIdList></Reference><Reference><Citation>Panchina Y., Kelmanson I., Matz M., Lukyanov K., Usman N., Lukyanov S. A ubiquitous family of putative gap junction molecules. Curr. Biol. 2000;10:R473&#x2013;R474. doi: 10.1016/S0960-9822(00)00576-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-9822(00)00576-5</ArticleId><ArticleId IdType="pubmed">10898987</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao L., Locovei S., Dahl G. Pannexin membrane channels are mechanosensitive conduits for ATP. FEBS Lett. 2004;572:65&#x2013;68. doi: 10.1016/j.febslet.2004.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2004.07.009</ArticleId><ArticleId IdType="pubmed">15304325</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruzzone R., Hormuzdi S.G., Barbe M.T., Herb A., Monyer H. Pannexins, a family of gap junction proteins expressed in brain. Proc. Natl. Acad. Sci. USA. 2003;100:13644&#x2013;13649. doi: 10.1073/pnas.2233464100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2233464100</ArticleId><ArticleId IdType="pmc">PMC263867</ArticleId><ArticleId IdType="pubmed">14597722</ArticleId></ArticleIdList></Reference><Reference><Citation>Locovei S., Wang J., Dahl G. Activation of pannexin 1 channels by ATP through P2Y receptors and by cytoplasmic calcium. FEBS Lett. 2006;580:239&#x2013;244. doi: 10.1016/j.febslet.2005.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2005.12.004</ArticleId><ArticleId IdType="pubmed">16364313</ArticleId></ArticleIdList></Reference><Reference><Citation>Locovei S., Scemes E., Qiu F., Spray D.C., Dahl G. Pannexin1 is part of the pore forming unit of the P2X 7 receptor death complex. FEBS Lett. 2007;581:483&#x2013;488. doi: 10.1016/j.febslet.2006.12.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2006.12.056</ArticleId><ArticleId IdType="pmc">PMC1868681</ArticleId><ArticleId IdType="pubmed">17240370</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu F., Dahl G. A permeant regulating its permeation pore: Inhibition of pannexin 1 channels by ATP. Am. J. Physiol. Physiol. 2009;296:C250&#x2013;C255. doi: 10.1152/ajpcell.00433.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00433.2008</ArticleId><ArticleId IdType="pmc">PMC2643853</ArticleId><ArticleId IdType="pubmed">18945939</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurtenbach S., Prochnow N., Kurtenbach S., Klooster J., Zoidl C., Dermietzel R., Kamermans M., Zoidl G. Pannexin1 Channel Proteins in the Zebrafish Retina Have Shared and Unique Properties. PLoS ONE. 2013;8:e77722. doi: 10.1371/journal.pone.0077722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0077722</ArticleId><ArticleId IdType="pmc">PMC3808535</ArticleId><ArticleId IdType="pubmed">24194896</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez X., Escamilla R., Fern&#xe1;ndez P., Duarte Y., Gonz&#xe1;lez-Nilo F., Palacios-Prado N., Martinez A.D., S&#xe1;ez J.C. Stretch-Induced Activation of Pannexin 1 Channels Can Be Prevented by PKA-Dependent Phosphorylation. Int. J. Mol. Sci. 2020;21:9180. doi: 10.3390/ijms21239180.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21239180</ArticleId><ArticleId IdType="pmc">PMC7731223</ArticleId><ArticleId IdType="pubmed">33276429</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson R.J., Zhou N., MacVicar B.A. Ischemia Opens Neuronal Gap Junction Hemichannels. Science. 2006;312:924&#x2013;927. doi: 10.1126/science.1126241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1126241</ArticleId><ArticleId IdType="pubmed">16690868</ArticleId></ArticleIdList></Reference><Reference><Citation>Iglesias R., Locovei S., Roque A., Alberto A.P., Dahl G., Spray D.C., Scemes E. P2X 7 receptor-Pannexin1 complex: Pharmacology and signaling. Am. J. Physiol. Physiol. 2008;295:C752&#x2013;C760. doi: 10.1152/ajpcell.00228.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00228.2008</ArticleId><ArticleId IdType="pmc">PMC2544446</ArticleId><ArticleId IdType="pubmed">18596211</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunse S., Locovei S., Schmidt M., Qiu F., Zoidl G., Dahl G., Dermietzel R. The potassium channel subunit Kv&#x3b2;3 interacts with pannexin 1 and attenuates its sensitivity to changes in redox potentials. FEBS J. 2009;276:6258&#x2013;6270. doi: 10.1111/j.1742-4658.2009.07334.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2009.07334.x</ArticleId><ArticleId IdType="pubmed">19780818</ArticleId></ArticleIdList></Reference><Reference><Citation>Chekeni F.B., Elliott M.R., Sandilos J.K., Walk S.F., Kinchen J.M., Lazarowski E.R., Armstrong A.J., Penuela S., Laird D.W., Salvesen G.S., et al. Pannexin 1 channels mediate &#x2018;find-me&#x2019; signal release and membrane permeability during apoptosis. Nature. 2010;467:863&#x2013;867. doi: 10.1038/nature09413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09413</ArticleId><ArticleId IdType="pmc">PMC3006164</ArticleId><ArticleId IdType="pubmed">20944749</ArticleId></ArticleIdList></Reference><Reference><Citation>Orellana J.A., Shoji K.F., Abudara V., Ezan P., Amigou E., Saez P.J., Jiang J.X., Naus C.C., Saez J.C., Giaume C. Amyloid -Induced Death in Neurons Involves Glial and Neuronal Hemichannels. J. Neurosci. 2011;31:4962&#x2013;4977. doi: 10.1523/JNEUROSCI.6417-10.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.6417-10.2011</ArticleId><ArticleId IdType="pmc">PMC6622997</ArticleId><ArticleId IdType="pubmed">21451035</ArticleId></ArticleIdList></Reference><Reference><Citation>Weilinger N.L., Tang P.L., Thompson R.J. Anoxia-Induced NMDA Receptor Activation Opens Pannexin Channels via Src Family Kinases. J. Neurosci. 2012;32:12579&#x2013;12588. doi: 10.1523/JNEUROSCI.1267-12.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1267-12.2012</ArticleId><ArticleId IdType="pmc">PMC6621249</ArticleId><ArticleId IdType="pubmed">22956847</ArticleId></ArticleIdList></Reference><Reference><Citation>Weilinger N.L., Maslieieva V., Bialecki J., Sridharan S.S., Tang P.L., Thompson R.J. Ionotropic receptors and ion channels in ischemic neuronal death and dysfunction. Acta Pharmacol. Sin. 2013;34:39&#x2013;48. doi: 10.1038/aps.2012.95.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2012.95</ArticleId><ArticleId IdType="pmc">PMC4086487</ArticleId><ArticleId IdType="pubmed">22864302</ArticleId></ArticleIdList></Reference><Reference><Citation>Beckel J.M., Argall A.J., Lim J.C., Xia J., Lu W., Coffey E.E., Macarak E.J., Shahidullah M., Delamere N.A., Zode G.S., et al. Mechanosensitive release of adenosine 5&#x2032;-triphosphate through pannexin channels and mechanosensitive upregulation of pannexin channels in optic nerve head astrocytes: A mechanism for purinergic involvement in chronic strain. Glia. 2014;62:1486&#x2013;1501. doi: 10.1002/glia.22695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22695</ArticleId><ArticleId IdType="pmc">PMC4133947</ArticleId><ArticleId IdType="pubmed">24839011</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivier E., Dutot M., Regazzetti A., Leguillier T., Darg&#xe8;re D., Auzeil N., Lapr&#xe9;vote O., Rat P. P2X7-pannexin-1 and amyloid &#x3b2;-induced oxysterol input in human retinal cell: Role in age-related macular degeneration? Biochimie. 2016;127:70&#x2013;78. doi: 10.1016/j.biochi.2016.04.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2016.04.014</ArticleId><ArticleId IdType="pubmed">27109381</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu F., Wang J., Dahl G. Alanine substitution scanning of pannexin1 reveals amino acid residues mediating ATP sensitivity. Purinergic Signal. 2012;8:81&#x2013;90. doi: 10.1007/s11302-011-9263-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11302-011-9263-6</ArticleId><ArticleId IdType="pmc">PMC3286540</ArticleId><ArticleId IdType="pubmed">21987098</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyce A.K.J., Swayne L.A. P2X7 receptor cross-talk regulates ATP-induced pannexin 1 internalization. Biochem. J. 2017;474:2133&#x2013;2144. doi: 10.1042/BCJ20170257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20170257</ArticleId><ArticleId IdType="pubmed">28495860</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma H.-T., Beaven M.A. Regulation of Ca2+ Signaling with Particular Focus on Mast Cells. Crit. Rev. Immunol. 2009;29:155&#x2013;186. doi: 10.1615/CritRevImmunol.v29.i2.40.</Citation><ArticleIdList><ArticleId IdType="doi">10.1615/CritRevImmunol.v29.i2.40</ArticleId><ArticleId IdType="pmc">PMC2954050</ArticleId><ArticleId IdType="pubmed">19496745</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilfillan A.M., Beaven M.A. Regulation of Mast Cell Responses in Health and Disease. Crit. Rev. Immunol. 2011;31:475&#x2013;530. doi: 10.1615/CritRevImmunol.v31.i6.30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1615/CritRevImmunol.v31.i6.30</ArticleId><ArticleId IdType="pmc">PMC3395887</ArticleId><ArticleId IdType="pubmed">22321108</ArticleId></ArticleIdList></Reference><Reference><Citation>Maldifassi M.C., Momboisse F., Guerra M.J., Vielma A.H., Maripill&#xe1;n J., B&#xe1;ez-Matus X., Flores-Mu&#xf1;oz C., C&#xe1;diz B., Schmachtenberg O., Mart&#xed;nez A.D., et al. The interplay between &#x3b1;7 nicotinic acetylcholine receptors, pannexin-1 channels and P2X7 receptors elicit exocytosis in chromaffin cells. J. Neurochem. 2020:jnc.15186. doi: 10.1111/jnc.15186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15186</ArticleId><ArticleId IdType="pubmed">32931038</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudheer P.S., Hall J.E., Donev R., Read G., Rowbottom A., Williams P.E. Nicotinic acetylcholine receptors on basophils and mast cells. Anaesthesia. 2006;61:1170&#x2013;1174. doi: 10.1111/j.1365-2044.2006.04870.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.2006.04870.x</ArticleId><ArticleId IdType="pubmed">17090238</ArticleId></ArticleIdList></Reference><Reference><Citation>Kageyama-Yahara N., Suehiro Y., Yamamoto T., Kadowaki M. IgE-induced degranulation of mucosal mast cells is negatively regulated via nicotinic acetylcholine receptors. Biochem. Biophys. Res. Commun. 2008;377:321&#x2013;325. doi: 10.1016/j.bbrc.2008.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2008.10.004</ArticleId><ArticleId IdType="pubmed">18848921</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H., Shi X., Li X., Zou J., Zhou C., Liu W., Shao H., Chen H., Shi L. Neurotransmitter and neuropeptide regulation of mast cell function: A systematic review. J. Neuroinflamm. 2020;17:356. doi: 10.1186/s12974-020-02029-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-02029-3</ArticleId><ArticleId IdType="pmc">PMC7691095</ArticleId><ArticleId IdType="pubmed">33239034</ArticleId></ArticleIdList></Reference><Reference><Citation>Vliagoftis H., Hutson A.M., Mahmudi-Azer S., Kim H., Rumsaeng V., Oh C.K., Moqbel R., Metcalfe D.D. Mast cells express connexins on their cytoplasmic membrane. J. Allergy Clin. Immunol. 1999;103:656&#x2013;662. doi: 10.1016/S0091-6749(99)70239-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0091-6749(99)70239-3</ArticleId><ArticleId IdType="pubmed">10200016</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliani S.M., Giro A.P., Smith R.L. Gap Junctions between Mast Cells and Fibroblasts in the Developing Avian Eye. Cells Tissues Organs. 1995;154:267&#x2013;271. doi: 10.1159/000147778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000147778</ArticleId><ArticleId IdType="pubmed">8773713</ArticleId></ArticleIdList></Reference><Reference><Citation>Moyer K.E., Saggers G.C., Ehrlich H.P. Mast cells promote fibroblast populated collagen lattice contraction through gap junction intercellular communication. Wound Repair Regen. 2004;12:269&#x2013;275. doi: 10.1111/j.1067-1927.2004.012310.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1067-1927.2004.012310.x</ArticleId><ArticleId IdType="pubmed">15225205</ArticleId></ArticleIdList></Reference><Reference><Citation>Pistorio A.L., Ehrlich H.P. Modulatory effects of connexin-43 expression on gap junction intercellular communications with mast cells and fibroblasts. J. Cell. Biochem. 2011;112:1441&#x2013;1449. doi: 10.1002/jcb.23061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.23061</ArticleId><ArticleId IdType="pmc">PMC3071433</ArticleId><ArticleId IdType="pubmed">21328609</ArticleId></ArticleIdList></Reference><Reference><Citation>Koulakoff A., Mei X., Orellana J.A., S&#xe1;ez J.C., Giaume C. Glial connexin expression and function in the context of Alzheimer&#x2019;s disease. Biochim. Biophys. Acta. 2012;1818:2048&#x2013;2057. doi: 10.1016/j.bbamem.2011.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamem.2011.10.001</ArticleId><ArticleId IdType="pubmed">22008509</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi H., Suzumura A. Gap junctions and hemichannels composed of connexins: Potential therapeutic targets for neurodegenerative diseases. Front. Cell. Neurosci. 2014;8 doi: 10.3389/fncel.2014.00189.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00189</ArticleId><ArticleId IdType="pmc">PMC4151093</ArticleId><ArticleId IdType="pubmed">25228858</ArticleId></ArticleIdList></Reference><Reference><Citation>Gajardo-G&#xf3;mez R., Labra V.C., Orellana J.A. Connexins and Pannexins: New Insights into Microglial Functions and Dysfunctions. Front. Mol. Neurosci. 2016;9 doi: 10.3389/fnmol.2016.00086.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2016.00086</ArticleId><ArticleId IdType="pmc">PMC5031785</ArticleId><ArticleId IdType="pubmed">27713688</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi C., Koulakoff A., Giaume C. Astroglial Connexins as a Therapeutic Target for Alzheimer&#x2019;s Disease. Curr. Pharm. Des. 2018;23 doi: 10.2174/1381612823666171004151215.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612823666171004151215</ArticleId><ArticleId IdType="pubmed">28982320</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing L., Yang T., Cui S., Chen G. Connexin Hemichannels in Astrocytes: Role in CNS Disorders. Front. Mol. Neurosci. 2019;12 doi: 10.3389/fnmol.2019.00023.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00023</ArticleId><ArticleId IdType="pmc">PMC6372977</ArticleId><ArticleId IdType="pubmed">30787868</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy J.I., Li W., Hertzberg E.L., Marotta C.A. Elevated connexin43 immunoreactivity at sites of amyloid plaques in alzheimer&#x2019;s disease. Brain Res. 1996;717:173&#x2013;178. doi: 10.1016/0006-8993(95)01526-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(95)01526-4</ArticleId><ArticleId IdType="pubmed">8738268</ArticleId></ArticleIdList></Reference><Reference><Citation>Mei X., Ezan P., Giaume C., Koulakoff A. Astroglial connexin immunoreactivity is specifically altered at &#x3b2;-amyloid plaques in &#x3b2;-amyloid precursor protein/presenilin1 mice. Neuroscience. 2010;171:92&#x2013;105. doi: 10.1016/j.neuroscience.2010.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2010.08.001</ArticleId><ArticleId IdType="pubmed">20813165</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi H., Mizoguchi H., Doi Y., Jin S., Noda M., Liang J., Li H., Zhou Y., Mori R., Yasuoka S., et al. Blockade of Gap Junction Hemichannel Suppresses Disease Progression in Mouse Models of Amyotrophic Lateral Sclerosis and Alzheimer&#x2019;s Disease. PLoS ONE. 2011;6:e21108. doi: 10.1371/journal.pone.0021108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0021108</ArticleId><ArticleId IdType="pmc">PMC3119678</ArticleId><ArticleId IdType="pubmed">21712989</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi C., Mei X., Ezan P., Mato S., Matias I., Giaume C., Koulakoff A. Astroglial connexin43 contributes to neuronal suffering in a mouse model of Alzheimer&#x2019;s disease. Cell Death Differ. 2016;23:1691&#x2013;1701. doi: 10.1038/cdd.2016.63.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2016.63</ArticleId><ArticleId IdType="pmc">PMC5041199</ArticleId><ArticleId IdType="pubmed">27391799</ArticleId></ArticleIdList></Reference><Reference><Citation>Abudara V., Roux L., Dall&#xe9;rac G., Matias I., Dulong J., Mothet J.P., Rouach N., Giaume C. Activated microglia impairs neuroglial interaction by opening Cx43 hemichannels in hippocampal astrocytes. Glia. 2015;63:795&#x2013;811. doi: 10.1002/glia.22785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22785</ArticleId><ArticleId IdType="pubmed">25643695</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi C., Ezan P., Fern&#xe1;ndez P., Schmitt J., S&#xe1;ez J.C., Giaume C., Koulakoff A. Inhibition of glial hemichannels by boldine treatment reduces neuronal suffering in a murine model of Alzheimer&#x2019;s disease. Glia. 2017;65:1607&#x2013;1625. doi: 10.1002/glia.23182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23182</ArticleId><ArticleId IdType="pubmed">28703353</ArticleId></ArticleIdList></Reference><Reference><Citation>Maslinska D., Laure-Kamionowska M., Maslinski K.T., Gujski M., Maslinski S. Distribution of tryptase-containing mast cells and metallothionein reactive astrocytes in human brains with amyloid deposits. Inflamm. Res. 2007;56:S17&#x2013;S18. doi: 10.1007/s00011-006-0508-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-006-0508-8</ArticleId><ArticleId IdType="pubmed">17806161</ArticleId></ArticleIdList></Reference><Reference><Citation>Kvetno&#x12d; I.M., Kvetnaia T.V., Riadnova I.I., Fursov B.B., Ernandes-Jago H., Blesa J.R. Expression of beta-amyloid and tau-protein in mastocytes in Alzheimer disease. Arkh. Patol. 2003;65:36&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">12669611</ArticleId></ArticleIdList></Reference><Reference><Citation>Niederhoffer N., Levy R., Sick E., Andre P., Coupin G., Lombard Y., Gies J.-P. Amyloid &#x3b2; Peptides Trigger CD47-Dependent Mast Cell Secretory and Phagocytic Responses. Int. J. Immunopathol. Pharmacol. 2009;22:473&#x2013;483. doi: 10.1177/039463200902200224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/039463200902200224</ArticleId><ArticleId IdType="pubmed">19505377</ArticleId></ArticleIdList></Reference><Reference><Citation>Sick E., Niederhoffer N., Takeda K., Landry Y., Gies J.-P. Activation of CD47 receptors causes histamine secretion from mast cells. Cell. Mol. Life Sci. 2009;66:1271&#x2013;1282. doi: 10.1007/s00018-009-8778-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-009-8778-2</ArticleId><ArticleId IdType="pubmed">19205621</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang J., Sloane J.A., Wells J.M., Abraham C.R., Fine R.E., Sipe J.D. Evidence for local production of acute phase response apolipoprotein serum amyloid A in Alzheimer&#x2019;s disease brain. Neurosci. Lett. 1997;225:73&#x2013;76. doi: 10.1016/S0304-3940(97)00196-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0304-3940(97)00196-1</ArticleId><ArticleId IdType="pubmed">9147377</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo J., Yu J., Grass D., de Beer F.C., Kindy M.S. Inflammation-Dependent Cerebral Deposition of Serum Amyloid A Protein in a Mouse Model of Amyloidosis. J. Neurosci. 2002;22:5900&#x2013;5909. doi: 10.1523/JNEUROSCI.22-14-05900.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.22-14-05900.2002</ArticleId><ArticleId IdType="pmc">PMC6757908</ArticleId><ArticleId IdType="pubmed">12122052</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsson N., Siegbahn A., Nilsson G. Serum Amyloid A Induces Chemotaxis of Human Mast Cells by Activating a Pertussis Toxin-Sensitive Signal Transduction Pathway. Biochem. Biophys. Res. Commun. 1999;254:143&#x2013;146. doi: 10.1006/bbrc.1998.9911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.1998.9911</ArticleId><ArticleId IdType="pubmed">9920747</ArticleId></ArticleIdList></Reference><Reference><Citation>Niemi K., Baumann M.H., Kovanen P.T., Eklund K.K. Serum amyloid A (SAA) activates human mast cells which leads into degradation of SAA and generation of an amyloidogenic SAA fragment. Biochim. Biophys. Acta. 2006;1762:424&#x2013;430. doi: 10.1016/j.bbadis.2006.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2006.01.001</ArticleId><ArticleId IdType="pubmed">16483749</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu W., Xu L., Pan J., Zheng X., Chen Z. Effect of cerebral ischemia on brain mast cells in rats. Brain Res. 2004;1019:275&#x2013;280. doi: 10.1016/j.brainres.2004.05.109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2004.05.109</ArticleId><ArticleId IdType="pubmed">15306264</ArticleId></ArticleIdList></Reference><Reference><Citation>Biran V., Cochois V., Karroubi A., Arrang J.M., Charriaut-Marlangue C., H&#xe9;ron A. Stroke Induces Histamine Accumulation and Mast Cell Degranulation in the Neonatal Rat Brain. Brain Pathol. 2008;18:1&#x2013;9. doi: 10.1111/j.1750-3639.2007.00092.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-3639.2007.00092.x</ArticleId><ArticleId IdType="pubmed">17924984</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattila O.S., Strbian D., Saksi J., Pikkarainen T.O., Rantanen V., Tatlisumak T., Lindsberg P.J. Cerebral Mast Cells Mediate Blood-Brain Barrier Disruption in Acute Experimental Ischemic Stroke Through Perivascular Gelatinase Activation. Stroke. 2011;42:3600&#x2013;3605. doi: 10.1161/STROKEAHA.111.632224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.111.632224</ArticleId><ArticleId IdType="pubmed">21980200</ArticleId></ArticleIdList></Reference><Reference><Citation>Strbian D., Karjalainen-Lindsberg M.-L., Kovanen P.T., Tatlisumak T., Lindsberg P.J. Mast Cell Stabilization Reduces Hemorrhage Formation and Mortality After Administration of Thrombolytics in Experimental Ischemic Stroke. Circulation. 2007;116:411&#x2013;418. doi: 10.1161/CIRCULATIONAHA.106.655423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.655423</ArticleId><ArticleId IdType="pubmed">17606844</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y., Silverman A.-J., Vannucci S.J. Mast Cell Stabilization Limits Hypoxic-Ischemic Brain Damage in the Immature Rat. Dev. Neurosci. 2007;29:373&#x2013;384. doi: 10.1159/000105478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000105478</ArticleId><ArticleId IdType="pubmed">17762205</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozada A., Maegele M., Stark H., Neugebauer E.M.A., Panula P. Traumatic brain injury results in mast cell increase and changes in regulation of central histamine receptors. Neuropathol. Appl. Neurobiol. 2005;31:150&#x2013;162. doi: 10.1111/j.1365-2990.2004.00622.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2990.2004.00622.x</ArticleId><ArticleId IdType="pubmed">15771708</ArticleId></ArticleIdList></Reference><Reference><Citation>Stokely M.E., Orr E.L. Acute Effects of Calvarial Damage on Dural Mast Cells, Pial Vascular Permeability, and Cerebral Cortical Histamine Levels in Rats and Mice. J. Neurotrauma. 2008;25:52&#x2013;61. doi: 10.1089/neu.2007.0397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2007.0397</ArticleId><ArticleId IdType="pubmed">18355158</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayed B.A., Christy A.L., Walker M.E., Brown M.A. Meningeal Mast Cells Affect Early T Cell Central Nervous System Infiltration and Blood-Brain Barrier Integrity through TNF: A Role for Neutrophil Recruitment? J. Immunol. 2010;184:6891&#x2013;6900. doi: 10.4049/jimmunol.1000126.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1000126</ArticleId><ArticleId IdType="pubmed">20488789</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinke K., Zorzella-Pezavento S.G., Lara V., Sartori A. Should mast cells be considered therapeutic targets in multiple sclerosis? Neural Regen. Res. 2020;15:1995. doi: 10.4103/1673-5374.282238.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.282238</ArticleId><ArticleId IdType="pmc">PMC7716037</ArticleId><ArticleId IdType="pubmed">32394947</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito P., Gheorghe D., Kandere K., Pang X., Connolly R., Jacobson S., Theoharides T.C. Acute stress increases permeability of the blood&#x2013;brain-barrier through activation of brain mast cells. Brain Res. 2001;888:117&#x2013;127. doi: 10.1016/S0006-8993(00)03026-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-8993(00)03026-2</ArticleId><ArticleId IdType="pubmed">11146058</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubreuil P., Letard S., Ciufolini M., Gros L., Humbert M., Cast&#xe9;ran N., Borge L., Hajem B., Lermet A., Sippl W., et al. Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT. PLoS ONE. 2009;4:e7258. doi: 10.1371/journal.pone.0007258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0007258</ArticleId><ArticleId IdType="pmc">PMC2746281</ArticleId><ArticleId IdType="pubmed">19789626</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T., Martin E., Abada Y., Boucher C., C&#xe8;s A., Youssef I., Fenaux G., Forand Y., Legrand A., Nachiket N., et al. Effects of Chronic Masitinib Treatment in APPswe/PSEN1dE9 Transgenic Mice Modeling Alzheimer&#x2019;s Disease. J. Alzheimer&#x2019;s Dis. 2020;76:1339&#x2013;1345. doi: 10.3233/JAD-200466.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-200466</ArticleId><ArticleId IdType="pubmed">32623401</ArticleId></ArticleIdList></Reference><Reference><Citation>Piette F., Belmin J., Vincent H., Schmidt N., Pariel S., Verny M., Marquis C., Mely J., Hugonot-Diener L., Kinet J.-P., et al. Masitinib as an adjunct therapy for mild-to-moderate Alzheimer&#x2019;s disease: A randomised, placebo-controlled phase 2 trial. Alzheimer&#x2019;s Res. Ther. 2011;3:16. doi: 10.1186/alzrt75.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/alzrt75</ArticleId><ArticleId IdType="pmc">PMC3226277</ArticleId><ArticleId IdType="pubmed">21504563</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermersch P., Benrabah R., Schmidt N., Z&#xe9;phir H., Clavelou P., Vongsouthi C., Dubreuil P., Moussy A., Hermine O. Masitinib treatment in patients with progressive multiple sclerosis: A randomized pilot study. BMC Neurol. 2012;12:36. doi: 10.1186/1471-2377-12-36.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-12-36</ArticleId><ArticleId IdType="pmc">PMC3467179</ArticleId><ArticleId IdType="pubmed">22691628</ArticleId></ArticleIdList></Reference><Reference><Citation>Folch J., Petrov D., Ettcheto M., Pedr&#xf3;s I., Abad S., Beas-Zarate C., Lazarowski A., Marin M., Olloquequi J., Auladell C., et al. Masitinib for the treatment of mild to moderate Alzheimer&#x2019;s disease. Expert Rev. Neurother. 2015;15:587&#x2013;596. doi: 10.1586/14737175.2015.1045419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14737175.2015.1045419</ArticleId><ArticleId IdType="pubmed">25961655</ArticleId></ArticleIdList></Reference><Reference><Citation>Mora J.S., Genge A., Chio A., Estol C.J., Chaverri D., Hern&#xe1;ndez M., Mar&#xed;n S., Mascias J., Rodriguez G.E., Povedano M., et al. Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: A randomized clinical trial. Amyotroph. Lateral Scler. Front. Degener. 2020;21:5&#x2013;14. doi: 10.1080/21678421.2019.1632346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1632346</ArticleId><ArticleId IdType="pubmed">31280619</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Spanos C., Pang X., Alferes L., Ligris K., Letourneau R., Rozniecki J.J., Webster E., Chrousos G.P. Stress-induced intracranial mast cell degranulation: A corticotropin-releasing hormone-mediated effect. Endocrinology. 1995;136:5745&#x2013;5750. doi: 10.1210/endo.136.12.7588332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/endo.136.12.7588332</ArticleId><ArticleId IdType="pubmed">7588332</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Ji P., Dow K.E. Corticotropin-releasing hormone induces proliferation and TNF-&#x3b1; release in cultured rat microglia via MAP kinase signalling pathways. J. Neurochem. 2002;84:189&#x2013;195. doi: 10.1046/j.1471-4159.2003.01544.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2003.01544.x</ArticleId><ArticleId IdType="pubmed">12485415</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao J., Papadopoulou N., Kempuraj D., Boucher W.S., Sugimoto K., Cetrulo C.L., Theoharides T.C. Human Mast Cells Express Corticotropin-Releasing Hormone (CRH) Receptors and CRH Leads to Selective Secretion of Vascular Endothelial Growth Factor. J. Immunol. 2005;174:7665&#x2013;7675. doi: 10.4049/jimmunol.174.12.7665.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.174.12.7665</ArticleId><ArticleId IdType="pubmed">15944267</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu J.K., Cho T., Choi H.B., Wang Y.T., McLarnon J.G. Microglial VEGF Receptor Response Is an Integral Chemotactic Component in Alzheimer&#x2019;s Disease Pathology. J. Neurosci. 2009;29:3&#x2013;13. doi: 10.1523/JNEUROSCI.2888-08.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2888-08.2009</ArticleId><ArticleId IdType="pmc">PMC6664925</ArticleId><ArticleId IdType="pubmed">19129379</ArticleId></ArticleIdList></Reference><Reference><Citation>Karagkouni A., Alevizos M., Theoharides T.C. Effect of stress on brain inflammation and multiple sclerosis. Autoimmun. Rev. 2013;12:947&#x2013;953. doi: 10.1016/j.autrev.2013.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2013.02.006</ArticleId><ArticleId IdType="pubmed">23537508</ArticleId></ArticleIdList></Reference><Reference><Citation>Kritas S.K., Saggini A., Cerulli G., Caraffa A., Antinolfi P., Pantalone A., Rosati M., Tei M., Speziali A., Saggini R., et al. Corticotropin-Releasing Hormone, Microglia and Mental Disorders. Int. J. Immunopathol. Pharmacol. 2014;27:163&#x2013;167. doi: 10.1177/039463201402700203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/039463201402700203</ArticleId><ArticleId IdType="pubmed">25004828</ArticleId></ArticleIdList></Reference><Reference><Citation>Skaper S.D., Facci L., Zusso M., Giusti P. An Inflammation-Centric View of Neurological Disease: Beyond the Neuron. Front. Cell. Neurosci. 2018;12 doi: 10.3389/fncel.2018.00072.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00072</ArticleId><ArticleId IdType="pmc">PMC5871676</ArticleId><ArticleId IdType="pubmed">29618972</ArticleId></ArticleIdList></Reference><Reference><Citation>Orellana J.A., Moraga-Amaro R., D&#xc3;-az-Galarce R., Rojas S., Maturana C.J., Stehberg J., S&#xc3;&#xa1;ez J.C. Restraint stress increases hemichannel activity in hippocampal glial cells and neurons. Front. Cell. Neurosci. 2015;9 doi: 10.3389/fncel.2015.00102.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00102</ArticleId><ArticleId IdType="pmc">PMC4382970</ArticleId><ArticleId IdType="pubmed">25883550</ArticleId></ArticleIdList></Reference><Reference><Citation>Maturana C.J., Aguirre A., S&#xe1;ez J.C. High glucocorticoid levels during gestation activate the inflammasome in hippocampal oligodendrocytes of the offspring. Dev. Neurobiol. 2017;77:625&#x2013;642. doi: 10.1002/dneu.22409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dneu.22409</ArticleId><ArticleId IdType="pubmed">27314460</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., Hardiman O. The epidemiology of ALS: A conspiracy of genes, environment and time. Nat. Rev. Neurol. 2013;9:617&#x2013;628. doi: 10.1038/nrneurol.2013.203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.203</ArticleId><ArticleId IdType="pubmed">24126629</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Chi&#xf2; A., Traynor B.J. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.P., Brown R.H., Cleveland D.W. Decoding ALS: From genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Abramzon Y.A., Fratta P., Traynor B.J., Chia R. The Overlapping Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Front. Neurosci. 2020;14 doi: 10.3389/fnins.2020.00042.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00042</ArticleId><ArticleId IdType="pmc">PMC7012787</ArticleId><ArticleId IdType="pubmed">32116499</ArticleId></ArticleIdList></Reference><Reference><Citation>Phatnani H., Maniatis T. Astrocytes in Neurodegenerative Disease: Table 1. Cold Spring Harb. Perspect. Biol. 2015;7:a020628. doi: 10.1101/cshperspect.a020628.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a020628</ArticleId><ArticleId IdType="pmc">PMC4448607</ArticleId><ArticleId IdType="pubmed">25877220</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai M., Re D.B., Nagata T., Chalazonitis A., Jessell T.M., Wichterle H., Przedborski S. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat. Neurosci. 2007;10:615&#x2013;622. doi: 10.1038/nn1876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1876</ArticleId><ArticleId IdType="pmc">PMC3799799</ArticleId><ArticleId IdType="pubmed">17435755</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-Phillips A.M., Hester M.E., Miranda C.J., Meyer K., Braun L., Frakes A., Song S., Likhite S., Murtha M.J., Foust K.D., et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat. Biotechnol. 2011;29:824&#x2013;828. doi: 10.1038/nbt.1957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1957</ArticleId><ArticleId IdType="pmc">PMC3170425</ArticleId><ArticleId IdType="pubmed">21832997</ArticleId></ArticleIdList></Reference><Reference><Citation>Fritz E., Izaurieta P., Weiss A., Mir F.R., Rojas P., Gonzalez D., Rojas F., Brown R.H., Madrid R., van Zundert B. Mutant SOD1-expressing astrocytes release toxic factors that trigger motoneuron death by inducing hyperexcitability. J. Neurophysiol. 2013;109:2803&#x2013;2814. doi: 10.1152/jn.00500.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.00500.2012</ArticleId><ArticleId IdType="pmc">PMC3680799</ArticleId><ArticleId IdType="pubmed">23486205</ArticleId></ArticleIdList></Reference><Reference><Citation>Re D.B., Le Verche V., Yu C., Amoroso M.W., Politi K.A., Phani S., Ikiz B., Hoffmann L., Koolen M., Nagata T., et al. Necroptosis Drives Motor Neuron Death in Models of Both Sporadic and Familial ALS. Neuron. 2014;81:1001&#x2013;1008. doi: 10.1016/j.neuron.2014.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.011</ArticleId><ArticleId IdType="pmc">PMC3951532</ArticleId><ArticleId IdType="pubmed">24508385</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas F., Cortes N., Abarzua S., Dyrda A., van Zundert B. Astrocytes expressing mutant SOD1 and TDP43 trigger motoneuron death that is mediated via sodium channels and nitroxidative stress. Front. Cell. Neurosci. 2014;8 doi: 10.3389/fncel.2014.00024.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00024</ArticleId><ArticleId IdType="pmc">PMC3916762</ArticleId><ArticleId IdType="pubmed">24570655</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikiz B., Alvarez M.J., R&#xe9; D.B., Le Verche V., Politi K., Lotti F., Phani S., Pradhan R., Yu C., Croft G.F., et al. The Regulatory Machinery of Neurodegeneration in In Vitro Models of Amyotrophic Lateral Sclerosis. Cell Rep. 2015;12:335&#x2013;345. doi: 10.1016/j.celrep.2015.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.06.019</ArticleId><ArticleId IdType="pmc">PMC4646662</ArticleId><ArticleId IdType="pubmed">26146077</ArticleId></ArticleIdList></Reference><Reference><Citation>Birger A., Ben-Dor I., Ottolenghi M., Turetsky T., Gil Y., Sweetat S., Perez L., Belzer V., Casden N., Steiner D., et al. Human iPSC-derived astrocytes from ALS patients with mutated C9ORF72 show increased oxidative stress and neurotoxicity. EBioMedicine. 2019;50:274&#x2013;289. doi: 10.1016/j.ebiom.2019.11.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2019.11.026</ArticleId><ArticleId IdType="pmc">PMC6921360</ArticleId><ArticleId IdType="pubmed">31787569</ArticleId></ArticleIdList></Reference><Reference><Citation>Varcianna A., Myszczynska M.A., Castelli L.M., O&#x2019;Neill B., Kim Y., Talbot J., Nyberg S., Nyamali I., Heath P.R., Stopford M.J., et al. Micro-RNAs secreted through astrocyte-derived extracellular vesicles cause neuronal network degeneration in C9orf72 ALS. EBioMedicine. 2019;40:626&#x2013;635. doi: 10.1016/j.ebiom.2018.11.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2018.11.067</ArticleId><ArticleId IdType="pmc">PMC6413467</ArticleId><ArticleId IdType="pubmed">30711519</ArticleId></ArticleIdList></Reference><Reference><Citation>Jury N., Abarzua S., Diaz I., Guerra M.V., Ampuero E., Cubillos P., Martinez P., Herrera-Soto A., Arredondo C., Rojas F., et al. Widespread loss of the silencing epigenetic mark H3K9me3 in astrocytes and neurons along with hippocampal-dependent cognitive impairment in C9orf72 BAC transgenic mice. Clin. Epigenet. 2020;12:32. doi: 10.1186/s13148-020-0816-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-020-0816-9</ArticleId><ArticleId IdType="pmc">PMC7029485</ArticleId><ArticleId IdType="pubmed">32070418</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra V., Re D.B., Le Verche V., Alvarez M.J., Vasciaveo A., Jacquier A., Doulias P.-T., Greco T.M., Nizzardo M., Papadimitriou D., et al. Systematic elucidation of neuron-astrocyte interaction in models of amyotrophic lateral sclerosis using multi-modal integrated bioinformatics workflow. Nat. Commun. 2020;11:5579. doi: 10.1038/s41467-020-19177-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19177-y</ArticleId><ArticleId IdType="pmc">PMC7642391</ArticleId><ArticleId IdType="pubmed">33149111</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkhratsky A., Matteoli M., Parpura V., Mothet J., Zorec R. Astrocytes as secretory cells of the central nervous system: Idiosyncrasies of vesicular secretion. EMBO J. 2016;35:239&#x2013;257. doi: 10.15252/embj.201592705.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201592705</ArticleId><ArticleId IdType="pmc">PMC4741299</ArticleId><ArticleId IdType="pubmed">26758544</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkhratsky A., Nedergaard M. Physiology of Astroglia. Physiol. Rev. 2018;98:239&#x2013;389. doi: 10.1152/physrev.00042.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00042.2016</ArticleId><ArticleId IdType="pmc">PMC6050349</ArticleId><ArticleId IdType="pubmed">29351512</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang N., De Bock M., Decrock E., Bol M., Gadicherla A., Vinken M., Rogiers V., Bukauskas F.F., Bultynck G., Leybaert L. Paracrine signaling through plasma membrane hemichannels. Biochim. Biophys. Acta Biomembr. 2013;1828:35&#x2013;50. doi: 10.1016/j.bbamem.2012.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamem.2012.07.002</ArticleId><ArticleId IdType="pmc">PMC3666170</ArticleId><ArticleId IdType="pubmed">22796188</ArticleId></ArticleIdList></Reference><Reference><Citation>Garre J.M., Yang G., Bukauskas F.F., Bennett M.V.L. FGF-1 Triggers Pannexin-1 Hemichannel Opening in Spinal Astrocytes of Rodents and Promotes Inflammatory Responses in Acute Spinal Cord Slices. J. Neurosci. 2016;36:4785&#x2013;4801. doi: 10.1523/JNEUROSCI.4195-15.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4195-15.2016</ArticleId><ArticleId IdType="pmc">PMC4846674</ArticleId><ArticleId IdType="pubmed">27122036</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong Y., Zhao T., Li X.-J., Li S. Mutant Huntingtin Impairs BDNF Release from Astrocytes by Disrupting Conversion of Rab3a-GTP into Rab3a-GDP. J. Neurosci. 2016;36:8790&#x2013;8801. doi: 10.1523/JNEUROSCI.0168-16.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0168-16.2016</ArticleId><ArticleId IdType="pmc">PMC4995297</ArticleId><ArticleId IdType="pubmed">27559163</ArticleId></ArticleIdList></Reference><Reference><Citation>Varela-Eirin M., Varela-Vazquez A., Rodr&#xed;guez-Candela Mateos M., Vila-Sanjurjo A., Fonseca E., Mascare&#xf1;as J.L., Eugenio V&#xe1;zquez M., Mayan M.D. Recruitment of RNA molecules by connexin RNA-binding motifs: Implication in RNA and DNA transport through microvesicles and exosomes. Biochim. Biophys. Acta Mol. Cell Res. 2017;1864:728&#x2013;736. doi: 10.1016/j.bbamcr.2017.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2017.02.001</ArticleId><ArticleId IdType="pubmed">28167212</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotrina M.L., Gao Q., Lin J.H.-C., Nedergaard M. Expression and function of astrocytic gap junctions in aging. Brain Res. 2001;901:55&#x2013;61. doi: 10.1016/S0006-8993(01)02258-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-8993(01)02258-2</ArticleId><ArticleId IdType="pubmed">11368950</ArticleId></ArticleIdList></Reference><Reference><Citation>Rochefort N., Quenech&#x2019;du N., Ezan P., Giaume C., Milleret C. Postnatal development of GFAP, connexin43 and connexin30 in cat visual cortex. Dev. Brain Res. 2005;160:252&#x2013;264. doi: 10.1016/j.devbrainres.2005.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devbrainres.2005.09.011</ArticleId><ArticleId IdType="pubmed">16297988</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Amarilla P., Olivera-Bravo S., Trias E., Cragnolini A., Martinez-Palma L., Cassina P., Beckman J., Barbeito L. Phenotypically aberrant astrocytes that promote motoneuron damage in a model of inherited amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 2011;108:18126&#x2013;18131. doi: 10.1073/pnas.1110689108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1110689108</ArticleId><ArticleId IdType="pmc">PMC3207668</ArticleId><ArticleId IdType="pubmed">22010221</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller A.F., Gravel M., Kriz J. Treatment with minocycline after disease onset alters astrocyte reactivity and increases microgliosis in SOD1 mutant mice. Exp. Neurol. 2011;228:69&#x2013;79. doi: 10.1016/j.expneurol.2010.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2010.12.010</ArticleId><ArticleId IdType="pubmed">21168408</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y., Masaki K., Yamasaki R., Imamura S., Suzuki S.O., Hayashi S., Sato S., Nagara Y., Kawamura M.F., Kira J. Extensive dysregulations of oligodendrocytic and astrocytic connexins are associated with disease progression in an amyotrophic lateral sclerosis mouse model. J. Neuroinflamm. 2014;11:42. doi: 10.1186/1742-2094-11-42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-11-42</ArticleId><ArticleId IdType="pmc">PMC4016493</ArticleId><ArticleId IdType="pubmed">24597481</ArticleId></ArticleIdList></Reference><Reference><Citation>Almad A.A., Doreswamy A., Gross S.K., Richard J.-P., Huo Y., Haughey N., Maragakis N.J. Connexin 43 in astrocytes contributes to motor neuron toxicity in amyotrophic lateral sclerosis. Glia. 2016;64:1154&#x2013;1169. doi: 10.1002/glia.22989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22989</ArticleId><ArticleId IdType="pmc">PMC5635605</ArticleId><ArticleId IdType="pubmed">27083773</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunha C., Santos C., Gomes C., Fernandes A., Correia A.M., Sebasti&#xe3;o A.M., Vaz A.R., Brites D. Downregulated Glia Interplay and Increased miRNA-155 as Promising Markers to Track ALS at an Early Stage. Mol. Neurobiol. 2017 doi: 10.1007/s12035-017-0631-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0631-2</ArticleId><ArticleId IdType="pubmed">28612258</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;hondt C., Ponsaerts R., De Smedt H., Bultynck G., Himpens B. Pannexins, distant relatives of the connexin family with specific cellular functions? BioEssays. 2009;31:953&#x2013;974. doi: 10.1002/bies.200800236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.200800236</ArticleId><ArticleId IdType="pubmed">19644918</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagos-Cabr&#xe9; R., Alvarez A., Kong M., Burgos-Bravo F., C&#xe1;rdenas A., Rojas-Mancilla E., P&#xe9;rez-Nu&#xf1;ez R., Herrera-Molina R., Rojas F., Schneider P., et al. &#x3b1;V&#x3b2;3 Integrin regulates astrocyte reactivity. J. Neuroinflam. 2017;14:194. doi: 10.1186/s12974-017-0968-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-017-0968-5</ArticleId><ArticleId IdType="pmc">PMC5622429</ArticleId><ArticleId IdType="pubmed">28962574</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Domenico A., Carola G., Calatayud C., Pons-Espinal M., Mu&#xf1;oz J.P., Richaud-Patin Y., Fernandez-Carasa I., Gut M., Faella A., Parameswaran J., et al. Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson&#x2019;s Disease. Stem Cell Rep. 2019;12:213&#x2013;229. doi: 10.1016/j.stemcr.2018.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2018.12.011</ArticleId><ArticleId IdType="pmc">PMC6372974</ArticleId><ArticleId IdType="pubmed">30639209</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiot A., Lobsiger C.S., Boill&#xe9;e S. New insights on the disease contribution of neuroinflammation in amyotrophic lateral sclerosis. Curr. Opin. Neurol. 2019;32:764&#x2013;770. doi: 10.1097/WCO.0000000000000729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000729</ArticleId><ArticleId IdType="pubmed">31306211</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones M.K., Nair A., Gupta M. Mast Cells in Neurodegenerative Disease. Front. Cell. Neurosci. 2019;13 doi: 10.3389/fncel.2019.00171.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00171</ArticleId><ArticleId IdType="pmc">PMC6524694</ArticleId><ArticleId IdType="pubmed">31133804</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Tsilioni I. Amyotrophic Lateral Sclerosis, Neuroinflammation, and Cromolyn. Clin. Ther. 2020;42:546&#x2013;549. doi: 10.1016/j.clinthera.2020.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2020.01.010</ArticleId><ArticleId IdType="pubmed">32044139</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E., Ibarburu S., Barreto-N&#xfa;&#xf1;ez R., Varela V., Moura I.C., Dubreuil P., Hermine O., Beckman J.S., Barbeito L. Evidence for mast cells contributing to neuromuscular pathology in an inherited model of ALS. JCI Insight. 2017;2 doi: 10.1172/jci.insight.95934.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.95934</ArticleId><ArticleId IdType="pmc">PMC5846907</ArticleId><ArticleId IdType="pubmed">29046475</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E., King P.H., Si Y., Kwon Y., Varela V., Ibarburu S., Kovacs M., Moura I.C., Beckman J.S., Hermine O., et al. Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS. JCI Insight. 2018;3 doi: 10.1172/jci.insight.123249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.123249</ArticleId><ArticleId IdType="pmc">PMC6237484</ArticleId><ArticleId IdType="pubmed">30282815</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E., Kovacs M., King P.H., Si Y., Kwon Y., Varela V., Ibarburu S., Moura I.C., Hermine O., Beckman J.S., et al. Schwann cells orchestrate peripheral nerve inflammation through the expression of CSF1, IL-34, and SCF in amyotrophic lateral sclerosis. Glia. 2020;68:1165&#x2013;1181. doi: 10.1002/glia.23768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23768</ArticleId><ArticleId IdType="pmc">PMC7269115</ArticleId><ArticleId IdType="pubmed">31859421</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E., Ibarburu S., Barreto-N&#xfa;&#xf1;ez R., Babdor J., Maciel T.T., Guillo M., Gros L., Dubreuil P., D&#xed;az-Amarilla P., Cassina P., et al. Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis. J. Neuroinflamm. 2016;13:177. doi: 10.1186/s12974-016-0620-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0620-9</ArticleId><ArticleId IdType="pmc">PMC4940876</ArticleId><ArticleId IdType="pubmed">27400786</ArticleId></ArticleIdList></Reference><Reference><Citation>Staats K.A., Sch&#xf6;nefeldt S., Van Helleputte L., Van Rillaer M., Lampi Y., Dooley J., Van Den Bosch L., Liston A. C-kit is important for SOD1G93A mouse survival independent of mast cells. Neuroscience. 2015;301:415&#x2013;420. doi: 10.1016/j.neuroscience.2015.06.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.06.026</ArticleId><ArticleId IdType="pubmed">26112382</ArticleId></ArticleIdList></Reference><Reference><Citation>Graves M., Fiala M., Dinglasan L.A., Liu N., Sayre J., Chiappelli F., van Kooten C., Vinters H. Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2004;5:213&#x2013;219. doi: 10.1080/14660820410020286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820410020286</ArticleId><ArticleId IdType="pubmed">15799549</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiala M., Chattopadhay M., La Cava A., Tse E., Liu G., Lourenco E., Eskin A., Liu P.T., Magpantay L., Tse S., et al. IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients. J. Neuroinflam. 2010;7:76. doi: 10.1186/1742-2094-7-76.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-7-76</ArticleId><ArticleId IdType="pmc">PMC2992053</ArticleId><ArticleId IdType="pubmed">21062492</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner T., Soffer D., Shalit M., Levi-Schaffer F. Mast cells in experimental allergic encephalomyelitis: Characterization, distribution in the CNS and in vitro activation by myelin basic protein and neuropeptides. J. Neurol. Sci. 1994;122:210&#x2013;213. doi: 10.1016/0022-510X(94)90300-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(94)90300-X</ArticleId><ArticleId IdType="pubmed">7517440</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanzola M.B., Robbie-Ryan M., Gutekunst C.A., Brown M.A. Mast Cells Exert Effects Outside the Central Nervous System to Influence Experimental Allergic Encephalomyelitis Disease Course. J. Immunol. 2003;171:4385&#x2013;4391. doi: 10.4049/jimmunol.171.8.4385.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.171.8.4385</ArticleId><ArticleId IdType="pubmed">14530364</ArticleId></ArticleIdList></Reference><Reference><Citation>Michaloudi H., Batzios C., Chiotelli M., Grivas I., Papadopoulos G.C. Mast cells populations fluctuate along the spinal dura mater of the developing rat. Brain Res. 2008;1226:8&#x2013;17. doi: 10.1016/j.brainres.2008.05.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2008.05.057</ArticleId><ArticleId IdType="pubmed">18621360</ArticleId></ArticleIdList></Reference><Reference><Citation>Granucci E.J., Griciuc A., Mueller K.A., Mills A.N., Le H., Dios A.M., McGinty D., Pereira J., Elmaleh D., Berry J.D., et al. Cromolyn sodium delays disease onset and is neuroprotective in the SOD1G93A Mouse Model of amyotrophic lateral sclerosis. Sci. Rep. 2019;9:17728. doi: 10.1038/s41598-019-53982-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-53982-w</ArticleId><ArticleId IdType="pmc">PMC6881366</ArticleId><ArticleId IdType="pubmed">31776380</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>